While the standard TZM-bl assay is widely used to screen the antiviral activity of antiviral molecules that interfere with HIV-1 replication, it measures the inhibition of HIV-1 replication as a function of the reduction in Tat-induced luciferase reporter gene expression after a single round of virus infection. This evidence concerns the gene TAT and viral infectious disease.